Cross-Border M&A in MENA: The Regulatory Approvals That Derail Transactions

Regulatory approvals can delay or prevent the closing of a MENA M&A transaction even after the commercial terms are agreed.

In cross-border transactions, parties often spend months negotiating valuation, warranties, indemnities, payment mechanics and closing deliverables, only to discover late in the process that the transaction cannot close on the expected timeline because a regulator has not approved the transfer, a competition filing was missed, a foreign ownership restriction applies, or a sector licence cannot be amended without further government review.

MENA jurisdictions typically require approvals from sector regulators, competition authorities, investment authorities, capital markets regulators, central banks, or in some cases national security and foreign investment review bodies. These approvals are not always sequential. They often run in parallel, each with its own documentation requirements, review period, and informal expectations around engagement.

There is no reliable region-wide clearance timetable. The parties most exposed are those who treat regulatory approval as a closing condition to be dealt with at the end, rather than a process to be managed from signing, and in some cases before signing.

MENA Is Not One Regulatory Market

One of the first mistakes in regional transactions is assuming that regulatory practice is broadly the same across MENA. It is not.

A transaction that is straightforward in one jurisdiction may require multiple filings in another. A share transfer that can be completed with a commercial registry update in one country may require ministerial consent, regulator clearance, foreign ownership review, or licence amendment in another. Even within the same country, the approval route may change depending on the sector, the nationality of the buyer, the identity of the ultimate beneficial owner, the source of financing, and whether the transaction involves land, strategic infrastructure, natural resources, financial services, telecoms, healthcare, logistics, or energy.

This means regulatory analysis should not begin with a generic country memo. It should begin with a transaction-specific approval map.

That map should identify:

• who the buyer is;
• who ultimately owns and controls the buyer;
• whether the target operates in a regulated sector;
• whether the target holds licences, permits, concessions, land rights or government contracts;
• whether the transaction triggers competition thresholds;
• whether foreign ownership restrictions apply;
• whether there are change-of-control restrictions in licences, contracts or financing documents;
• whether approvals are required before signing, before closing, or after closing.

Without this map, parties may sign documents that are commercially attractive but practically difficult to close.

The Approvals That Most Often Cause Delay

The approvals that derail M&A transactions in MENA usually fall into five categories.

First, sector approvals. These are often the most important. Banks, insurance companies, telecom operators, healthcare businesses, energy projects, mining companies, logistics operators, schools, pharmaceutical businesses and infrastructure assets may require approval from their sector regulator before a direct or indirect change of control. In some cases, the regulator is less concerned with the transaction documents than with the identity, experience and financial standing of the buyer.

Second, competition approvals. Merger control rules across the region are becoming more active and more sophisticated. Parties should not assume that competition filings are only required in very large transactions. Some jurisdictions examine local turnover, market share, transaction value, or the effect of the transaction on local markets. Failure to file can expose the parties to fines, closing delays, or even challenges to the transaction after completion.

Third, foreign investment and ownership restrictions. Certain sectors may be subject to foreign ownership caps, local partner requirements, special licensing conditions, or restrictions on ownership by specific categories of investors. These restrictions may not always appear in one statute. They may be found in sector regulations, licensing practice, investment authority requirements, land ownership rules, concession agreements or government policy.

Fourth, capital markets and listed company approvals. Where the target is listed, or where the transaction involves a listed parent, additional rules may apply. These can include mandatory tender offer requirements, disclosure obligations, related-party transaction approvals, shareholder approvals, valuation requirements, and stock exchange procedures. The timing of these steps can affect the entire deal calendar.

Fifth, national security and strategic asset review. Some transactions attract closer government attention because of the asset involved, the identity of the investor, the country of origin of the investor, or the political and economic sensitivity of the sector. This is particularly relevant for infrastructure, ports, logistics, energy, telecommunications, data, natural resources, defence-adjacent services and major industrial assets.

The Informal Process Matters

In many MENA jurisdictions, the formal legal requirements are only part of the process. The informal process can be just as important.

A filing may be legally complete but still move slowly if the regulator has questions about the buyer, the structure, the source of funds, or the impact on local operations. In some cases, ministries or regulators expect early engagement before a formal filing is submitted. In others, a regulator may want comfort that employees will be retained, investment commitments will be honoured, local suppliers will not be disrupted, or the business will continue operating in a manner consistent with national policy.

This does not mean the process is arbitrary. It means the transaction team must understand both the written rules and the practical expectations of the relevant authorities.

Good regulatory engagement is not lobbying after a problem arises. It is disciplined preparation. It requires clear messaging, complete documents, credible local counsel, and a transaction narrative that answers the regulator’s practical concerns.

Common Mistakes in Transaction Documents

Regulatory approvals should be reflected properly in the transaction documents. Too often, they are not.

A generic condition precedent stating that “all required regulatory approvals shall be obtained” is rarely enough. The agreement should identify the specific approvals required, the party responsible for making each filing, the level of cooperation expected from the other party, the timetable for submissions, the standard of effort required, and the consequences if approvals are delayed, granted with conditions, or refused.

Parties should also consider whether the buyer must accept regulatory conditions. For example, is the buyer required to accept employee retention commitments, divestment conditions, local ownership adjustments, reporting obligations, investment undertakings, or restrictions on integration? If so, how far must the buyer go? If not, who bears the risk if the regulator requires those conditions?

The long-stop date should also be realistic. A long-stop date that does not reflect the approval timeline creates unnecessary pressure and may hand one party leverage if approvals are delayed. In regulated sectors, three months may be optimistic. In more complex transactions, six to nine months may be more realistic.

The same applies to interim covenants. Between signing and closing, the seller usually remains in control of the target. However, the buyer may want restrictions on major decisions. These restrictions must be drafted carefully so they do not amount to unlawful control before closing, particularly where competition clearance or sector approval has not yet been obtained.

Regulatory Risk Is Also Commercial Risk

Regulatory approval is not a purely legal issue. It affects valuation, financing, timing, leverage and deal certainty.

A buyer may need to price the risk of delay into the transaction. A seller may resist a long conditional period if it creates uncertainty for the business. Lenders may require evidence that approvals can be obtained before committing funds. Employees may become unsettled if the approval process is poorly communicated. Customers and suppliers may question whether the business will remain stable after closing.

In some cases, the approval process can also change the economics of the deal. A regulator may require the buyer to maintain local operations, preserve employment levels, invest additional capital, appoint local management, or restructure ownership. These conditions can affect the buyer’s integration plan and expected return.

For that reason, regulatory approval should be treated as a core deal issue, not an administrative step.

What Parties Should Do Before Signing

Before signing a cross-border M&A transaction in MENA, parties should complete a focused regulatory readiness review.

That review should answer five questions.

First, what approvals are legally required?

Second, what approvals are practically expected, even if the law is not explicit?

Third, who needs to be engaged before filing?

Fourth, what documents will be required, and do they need translation, notarisation, authentication or legalisation?

Fifth, what is the realistic approval timeline, including possible delays?

This review should be completed early enough to affect the transaction structure. Sometimes the answer is not simply to wait for approval. The parties may need to adjust the buyer entity, add a local shareholder, restructure the acquisition as an asset sale, carve out regulated assets, obtain pre-signing comfort, or build a phased closing mechanism.

The Importance of Local Execution

Cross-border counsel often lead M&A transactions from London, New York, Dubai, Paris, Singapore or Toronto. That can work well for the main transaction documents. But local execution in MENA is critical.

Local counsel should not be brought in only to produce a legal opinion at closing. They should be involved early enough to test the structure against local law and regulatory practice. They should also coordinate with notaries, commercial registries, investment authorities, ministries, sector regulators, tax advisers and translation/legalisation providers.

In many transactions, the delay is not caused by the main legal issue. It is caused by missing corporate documents, inconsistent names across notarised documents, expired powers of attorney, unlegalised board resolutions, unclear beneficial ownership information, or filing forms that do not match the transaction structure.

These issues are avoidable, but only if they are identified early.

Conclusion

Cross-border M&A in MENA can be highly attractive, particularly in sectors such as energy, infrastructure, logistics, healthcare, technology, manufacturing and financial services. But the regulatory approval process must be treated as a central part of the transaction strategy.

The best transactions are not those that ignore regulatory complexity. They are those that identify it early, allocate it clearly, engage government stakeholders properly, and build a realistic closing path into the deal documents.

For investors, sellers and international counsel, the practical lesson is simple: regulatory approvals should not be left until the end. In MENA M&A, they are often the difference between a signed deal and a closed deal.

MEASA supports foreign investors, regional businesses and international counsel on market entry, regulatory approvals, corporate transactions and government-facing legal strategy across Egypt and the wider MENA region.